Brown JR - Search Results

1

Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.

Davids MS, Deng J, Wiestner A, Lannutti BJ, Wang L, Wu CJ, Wilson WH, Brown JR, Letai A. Davids MS, et al. Among authors: brown jr. Blood. 2012 Oct 25;120(17):3501-9. doi: 10.1182/blood-2012-02-414060. Epub 2012 Sep 5. Blood. 2012. PMID: 22955911 Free PMC article.

2

Chronic lymphocytic leukemia: a niche for flavopiridol?

Brown JR. Brown JR. Clin Cancer Res. 2005 Jun 1;11(11):3971-3. doi: 10.1158/1078-0432.CCR-05-0831. Clin Cancer Res. 2005. PMID: 15930331 No abstract available.

3

Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.

Brown JR, Kim HT, Li S, Stephans K, Fisher DC, Cutler C, Ho V, Lee SJ, Milford EL, Ritz J, Antin JH, Soiffer RJ, Gribben JG, Alyea EP. Brown JR, et al. Biol Blood Marrow Transplant. 2006 Oct;12(10):1056-64. doi: 10.1016/j.bbmt.2006.06.004. Biol Blood Marrow Transplant. 2006. PMID: 17084369 Free article.

4

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

Del Gaizo Moore V, Brown JR, Certo M, Love TM, Novina CD, Letai A. Del Gaizo Moore V, et al. Among authors: brown jr. J Clin Invest. 2007 Jan;117(1):112-21. doi: 10.1172/JCI28281. J Clin Invest. 2007. PMID: 17200714 Free PMC article.

5

Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Ghia EM, Jain S, Widhopf GF 2nd, Rassenti LZ, Keating MJ, Wierda WG, Gribben JG, Brown JR, Rai KR, Byrd JC, Kay NE, Greaves AW, Kipps TJ. Ghia EM, et al. Among authors: brown jr. Blood. 2008 May 15;111(10):5101-8. doi: 10.1182/blood-2007-12-130229. Epub 2008 Mar 7. Blood. 2008. PMID: 18326815 Free PMC article.

6

Pseudohyperkalemia in chronic lymphocytic leukemia.

Ruddy KJ, Wu D, Brown JR. Ruddy KJ, et al. Among authors: brown jr. J Clin Oncol. 2008 Jun 1;26(16):2781-2. doi: 10.1200/JCO.2008.16.3014. J Clin Oncol. 2008. PMID: 18509189 No abstract available.

7

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.

Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, Byrd JC, Kay NE, Brown JR, Gribben JG, Neuberg DS, He F, Greaves AW, Rai KR, Kipps TJ. Rassenti LZ, et al. Among authors: brown jr. Blood. 2008 Sep 1;112(5):1923-30. doi: 10.1182/blood-2007-05-092882. Epub 2008 Jun 24. Blood. 2008. PMID: 18577710 Free PMC article.

8

Inherited predisposition to chronic lymphocytic leukemia.

Brown JR. Brown JR. Expert Rev Hematol. 2008 Oct;1(1):51-61. doi: 10.1586/17474086.1.1.51. Expert Rev Hematol. 2008. PMID: 19802369 Free PMC article. Review.

9

Immunomodulators in chronic lymphocytic leukemia: where does lenalidomide belong?

Brown JR. Brown JR. Leuk Lymphoma. 2010 Aug;51(8):1382-5. doi: 10.3109/10428194.2010.496017. Leuk Lymphoma. 2010. PMID: 20624030

10

Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.

Danilov AV, Danilova OV, Brown JR, Rabinowitz A, Klein AK, Huber BT. Danilov AV, et al. Among authors: brown jr. Exp Hematol. 2010 Dec;38(12):1167-77. doi: 10.1016/j.exphem.2010.08.008. Epub 2010 Sep 24. Exp Hematol. 2010. PMID: 20817072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,898 results

Search Page

Filters